drugset / Trial / NCT04632706
Exploratory Ph I Trial of the Active IMP in Healthy Volunteers in Relation to COVID-19
RandomizedSequentialDouble-blindOther
Summary
An early stage trial to check how safe and tolerable, as well as how the body handles continuous daily use of Active IMP over 28 days in healthy volunteers.
Timeline
- Start
- 2020-09-22
- Primary completion
- 2021-03-09
- Completion
- 2021-03-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivermectin | Small molecule | 50 ug/kg | Oral |
| Subject | Ivermectin | Small molecule | 75 ug/kg | Oral |
| Subject | Ivermectin | Small molecule | 100 ug/kg | Oral |